{"id":"W2019925885","doi":"10.1016/j.clcc.2013.12.002","title":"Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147","year":2014,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"FOLFIRI; Medicine; Cetuximab; Irinotecan; KRAS; Colorectal cancer; Internal medicine; Oncology; FOLFOX; Clinical endpoint; Hazard ratio; Randomized controlled trial; Cancer; Surgery; Oxaliplatin; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000437766,0.0004740167,0.002312475,0.0001171075,0.0001175902,0.00002477977,0.0002316174,0.0002555357,0.0004211074],"category_scores_gemma":[0.0003509458,0.0002835288,0.0001844437,0.0007004988,0.0006337006,0.0001272825,0.0001279658,0.0006680413,0.000004339806],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006093953,"about_ca_system_score_gemma":0.0006848974,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00187989,"about_ca_topic_score_gemma":0.05280071,"domain_scores_codex":[0.9962478,0.0002424878,0.001313792,0.0008519405,0.0007452645,0.0005986853],"domain_scores_gemma":[0.9974787,0.0006043036,0.0007025356,0.0003877592,0.0005537781,0.0002728711],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3855565,0.00196172,0.6034093,0.0001099486,0.0003839878,0.000008868938,0.0003594358,0.00002188457,0.00002588148,0.000009242393,0.000500195,0.007653024],"study_design_scores_gemma":[0.1848101,0.06323745,0.7454749,0.0009928229,0.0004602607,7.75946e-7,0.0002362874,0.0005310551,0.0006266565,0.000005313398,0.003215793,0.0004086241],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938639,0.0005267428,0.0000240029,0.0003162993,0.000718269,0.002901908,0.00008973571,0.00007293988,0.001486251],"genre_scores_gemma":[0.9969993,0.0002661404,0.0002576453,0.0002616422,0.0003466046,0.0009366652,0.00004401418,0.00006750061,0.0008204782],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2007464,"threshold_uncertainty_score":0.9999617,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06875470791630059,"score_gpt":0.4297178547705361,"score_spread":0.3609631468542355,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}